Systemic coagulation reactivation in recurrence of colorectal cancer

Thrombosis and Haemostasis

Volumn 89, Issue 4, 2003, Pages 726-734

  Iversen, Lene H ^a   Thorlacius Ussing, Ole ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Blood coagulation; Colorectal neoplasms; Prognosis; Prospective studies; Recurrence

Indexed keywords

ENOXAPARIN; FIBRIN; FLUOROURACIL; HEPARIN; LEVAMISOLE; PLACEBO; PROTHROMBIN; PROTHROMBIN FRAGMENT 1 PLUS 2; THROMBIN ANTITHROMBIN COMPLEX; UNCLASSIFIED DRUG;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD SAMPLING; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EXCISION; FEMALE; FOLLOW UP; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC ACTIVATION; PATIENT MONITORING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; THROMBOSIS;

EID: 0037391961     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613579     Document Type: Article

References (29)

1. Dano K, Andreasen PA, Grondahl Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985; 44: 139-266.
2. Costantini V, Zacharski LR. Fibrin and cancer. Thromb Haemost 1993; 69: 406-14.
3. ENOXACAN Study Group. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicenter trial with venographic assessment. Br J Surg 1997; 84: 1099-103.
4. Iversen LH, Thorlacius-Ussing O. Relationship of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer. Thromb Haemost 2002; 87: 402-8.
5. Prandoni P, Lensing AW, Buller HR, Cogo A, Prins MH, Catelan AM, Cuppini S, Noventa F, Ten Cate JW. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327: 1128-33.
6. Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998; 338: 1169-73.
7. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992; 11: 237-48.
8. Iversen LH, Okholm M, Thorlacius Ussing O. Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease - A preliminary study. Thromb Haemost 1996; 76: 523-8.
9. Iversen LH. Coagulation and fibrinolysis in patients undergoing surgery for colorectal cancer - As assessed by sensitive markers. Ph.D.-thesis. Aalborg; 1997.
10. Pelzer H, Schwarz A, Stuber W. Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991; 65: 153-9.
11. Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988; 59: 101-6.
12. Lill H, Spannagl M, Trauner A, Schramm W, Schuller D, Ofenloch Haehnle B, Draeger B, Naser W, Dessauer A. A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo. Blood Coagul Fibrinolysis 1993; 4: 97-102.
13. Bland JM, Altman DG. The use of transformation when comparing two means. BMJ 1996; 312: 1153
14. Lowe GD, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, Tunstall Pedoe H. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 1997; 97: 775-84.
15. Rickles FR, Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thromb Res 2001; 102: V215-V224
16. Gouin-Thibault I, Achkar A, Samama MM. The thrombophilic state in cancer patients. Acta Haematol 2001; 106: 33-42.
17. Lip GY, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol 2002; 3: 27-34.
18. Lindahl AK, Odegaard OR, Sandset PM, Harbitz TB. Coagulation inhibition and activation in pancreatic cancer. Changes during progress of disease. Cancer 1992; 70: 2067-72.
19. Levi M. Cancer and DIC. Haemostasis 2001; 31 Suppl 1: 47-8.
20. Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigounas G. Disseminated intravascular coagulation in solid tumors: Clinical and pathologic study. Thromb Haemost 2001; 86: 828-33.
21. Wojtukiewicz MZ, Zacharski LR, Moritz TE, Hur K, Edwards RL, Rickles FR. Prognostic significance of blood coagulation tests in carcinoma of the lung and colon. Blood Coagul Fibrinolysis 1992; 3: 429-37.
22. Ferrigno D, Buccheri G, Ricca I. Prognostic significance of blood coagulation tests in lung cancer. Eur Respir J 2001; 17: 667-73.
23. Seitz R, Rappe N, Kraus M, Immel A, Wolf M, Maasberg M, Egbring R, Pfab R, Havemann K. Activation of coagulation and fibrinolysis in patients with lung cancer: Relation to tumour stage and prognosis. Blood Coagul Fibrinolysis 1993; 4: 249-54.
24. Gadducci A, Baicchi U, Marrai R, Facchini V, Del Bravo B, Fosella PV, Fioretti P. Pre-treatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with operable cervical cancer: Influence of surgical-pathological stage, tumor size, histologic type, and lymph node status. Gynecol Oncol 1993; 49: 354-8.
25. Gadducci A, Baicchi U, Marrai R, Del Bravo B, Fosella PV, Facchini V. Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with ovarian carcinoma. Gynecol Oncol 1994; 53: 352-6.
26. Iversen LH, Thorlacius Ussing O. Short-time stability of markers of coagulation and fibrinolysis in frozen plasma. Thromb Res 1996; 81: 253-61.
27. Pokorny RM, Hunt L, Galandiuk S. What's new with tumor markers for colorectal cancer? Dig Surg 200; 17: 209-15.
28. Mannucci PM. Mechanisms, markers and management of coagulation activation. Br Med Bull 1994; 50: 851-70.
29. Chang HR, Bland KI. Zinner M, Schwartz SI, Ellis H, editors. Maingot's Abdominal Operations. 10 ed. Connecticut: Appleton & Lange. Tumors of the colon. 1997; 421: 281-308.